What you need to know about percussion therapy
A new study says that while percussion therapy is widely used for the treatment of arthritis, it has no scientific basis.
But for many, the potential benefits are obvious.
Dr. Mark H. R. Siegel is the director of the Institute of Neurology at Columbia University, where he directs the Center for Neurological Surgery.
“If we can get to a point where this is an accepted medical therapy, it could have enormous implications for the medical care of patients with arthritis.” “
The study, published in the New England Journal of Medicine, is the first to investigate the efficacy of percussion therapy in treating arthritis. “
If we can get to a point where this is an accepted medical therapy, it could have enormous implications for the medical care of patients with arthritis.”
The study, published in the New England Journal of Medicine, is the first to investigate the efficacy of percussion therapy in treating arthritis.
The researchers studied the results of more than 20,000 patients with chronic arthritis in the United States who were prescribed either one or two types of therapy.
They found that patients who were on one of these medications had a significantly lower rate of the chronic arthritis-related complications that accompany chronic pain and arthritis.
They also had a reduced rate of pain, pain-related symptoms and disability.
The findings were so significant, in fact, that the researchers felt compelled to conduct a second study to determine whether these benefits might apply to other conditions.
The study involved nearly 10,000 individuals in New York State.
Participants were recruited between the ages of 55 and 90 and included patients who had been diagnosed with arthritis, musculoskeletal pain, depression, or anxiety disorders, as well as those with no or mild traumatic brain injury.
The subjects had been using either one of the newer medications or a placebo for more than two years, and were followed for six months.
Researchers asked each of the subjects whether they were currently using any of the medications.
About 1.4 percent of the participants were currently on either of the new medications.
They had been taking either the non-invasive ultrasound device, a nasal spray or a subcutaneous injection for a total of four years.
The other participants were either using the ultrasound device or the nasal spray for less than two weeks.
The scientists found that those on one or both of the drugs had a significant reduction in their pain-induced disability and disability-related quality of life.
“These patients had less pain, lower disability-associated symptoms, and less disability-based quality of care than their non-using counterparts,” said Siegel.
“This suggests that the noninvasive imaging may actually be a viable alternative for these patients.”
They were also less likely to develop musculo-skeletal joint pain or to develop pain-associated fatigue.
The next step is to determine if the reduction in pain-Related Quality of Life can be extended to other types of arthritis.
Shesis says that this study suggests that some patients may be better off with a non-intrusive treatment, such as ultrasound or subcutaneously injected corticosteroids, than with a traditional surgery.
“The study demonstrates that noninvasively administered corticosterone may be a more effective treatment for patients with osteoarthritis and other forms of chronic arthritis,” he said.
“Osteoarthrosis is one of a large group of diseases that is associated with lower quality of functioning, higher incidence of chronic conditions, and a lower rate in the elderly.”
The researchers say they have not yet conducted an analysis of the long-term effects of the treatment on health.
The potential benefits of this therapy are clear.
Sussiegel said, “There are many indications for noninjectable corticostegis to treat patients with rheumatoid arthritis and other conditions.”
In addition to pain, patients who have arthritis also have chronic fatigue, sleep problems, and loss of balance.
For example, chronic fatigue can affect people with rhemus, a group of muscle-wasting connective tissue cells that are found in joints.
The patients who received the ultrasound-based therapy were less likely than their peers on the placebo to have these problems.
They were less often in pain and more likely to be able to do simple activities such as walking.
They reported more fatigue and less fatigue-related pain.
Sarge, the lead author of the study, said, “[This] study demonstrates the potential for non-interventional imaging to provide effective treatment of chronic fatigue and other fatigue-associated disorders.
It also provides the first evidence that non-infrared radiotherapy is safe and effective in treating chronic pain in rheumatic patients.”
In future studies, the researchers will determine if noninstrumental radiotherapy can be used to treat arthritis and musculotic joint pain in patients with other conditions as well.
They are also studying whether ultrasound therapy can be safely and effectively used to manage the common inflammatory conditions of chronic inflammation and arthritis, such the chronic fatigue.